{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=A+placebo+cream", "query": { "intervention": "A placebo cream" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 251, "total_pages": 26, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=A+placebo+cream&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-23T11:45:00.668Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04921969", "title": "A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Ruxolitinib", "type": "DRUG" }, { "name": "Vehicle Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "2 Years to 11 Years" }, "enrollment_count": 330, "start_date": "2021-07-19", "completion_date": "2024-04-08", "has_results": true, "last_update_posted_date": "2025-03-28", "last_synced_at": "2026-09-23T11:45:00.668Z", "location_count": 64, "location_summary": "Birmingham, Alabama • Hoover, Alabama • Gilbert, Arizona + 49 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04921969" }, { "nct_id": "NCT00750139", "title": "Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tinea Pedis", "Athlete's Foot" ], "interventions": [ { "name": "NAFT-500", "type": "DRUG" }, { "name": "Placebo 2-weeks", "type": "DRUG" }, { "name": "Naftin 1%", "type": "DRUG" }, { "name": "Placebo 4-weeks", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merz North America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 707, "start_date": "2008-08", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2013-04-26", "last_synced_at": "2026-09-23T11:45:00.668Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miramar", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00750139" }, { "nct_id": "NCT02024581", "title": "A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Molluscum Contagiosum" ], "interventions": [ { "name": "10% East Indian sandalwood oil cream", "type": "DRUG" }, { "name": "Placebo Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViroXis Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 27, "start_date": "2016-02", "completion_date": "2017-09-21", "has_results": false, "last_update_posted_date": "2019-04-16", "last_synced_at": "2026-09-23T11:45:00.668Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02024581" }, { "nct_id": "NCT03850483", "title": "Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "PF-06700841", "type": "DRUG" }, { "name": "Vehicle (Placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 344, "start_date": "2019-04-08", "completion_date": "2021-04-20", "has_results": true, "last_update_posted_date": "2022-06-29", "last_synced_at": "2026-09-23T11:45:00.668Z", "location_count": 38, "location_summary": "Scottsdale, Arizona • Hot Springs, Arkansas • Anaheim, California + 31 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03850483" }, { "nct_id": "NCT00686231", "title": "Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Nitroglycerin 15mg", "type": "DRUG" }, { "name": "Nitroglycerin 30mg", "type": "DRUG" }, { "name": "Lidocaine 20mg", "type": "DRUG" }, { "name": "Lidocaine 40mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 19, "start_date": "2008-05", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2020-03-06", "last_synced_at": "2026-09-23T11:45:00.668Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00686231" }, { "nct_id": "NCT05763082", "title": "Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "roflumilast cream 0.3%", "type": "DRUG" }, { "name": "Zoryve", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Padagis LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 416, "start_date": "2023-02-07", "completion_date": "2023-08-08", "has_results": true, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-09-23T11:45:00.668Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT05763082" }, { "nct_id": "NCT04586816", "title": "Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Photoaging", "Hyperpigmentation", "Rhytides" ], "interventions": [ { "name": "1% red maple leaf extract in cream base", "type": "COMBINATION_PRODUCT" }, { "name": "5% red maple leaf extract", "type": "COMBINATION_PRODUCT" }, { "name": "vehicle", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Integrative Skin Science and Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "30 Years to 70 Years · Female only" }, "enrollment_count": 19, "start_date": "2019-09-10", "completion_date": "2020-01-15", "has_results": false, "last_update_posted_date": "2020-10-14", "last_synced_at": "2026-09-23T11:45:00.668Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04586816" }, { "nct_id": "NCT04211389", "title": "Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Plaque Psoriasis" ], "interventions": [ { "name": "ARQ-151 0.3% cream", "type": "DRUG" }, { "name": "ARQ-151 vehicle cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arcutis Biotherapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 442, "start_date": "2019-12-17", "completion_date": "2020-11-23", "has_results": true, "last_update_posted_date": "2022-12-07", "last_synced_at": "2026-09-23T11:45:00.668Z", "location_count": 31, "location_summary": "Scottsdale, Arizona • Beverly Hills, California • Encino, California + 26 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04211389" }, { "nct_id": "NCT07508124", "title": "Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Urinary Tract Infection" ], "interventions": [ { "name": "betamethasone valerate 0.1% cream", "type": "DRUG" }, { "name": "Placebo cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Months", "maximum_age": "5 Months", "sex": "MALE", "summary": "0 Months to 5 Months · Male only" }, "enrollment_count": 40, "start_date": "2026-05-08", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-08-07", "last_synced_at": "2026-09-23T11:45:00.668Z", "location_count": 3, "location_summary": "Houston, Texas • Katy, Texas • Seattle, Washington", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Katy", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT07508124" }, { "nct_id": "NCT05078827", "title": "Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Actinic Keratoses" ], "interventions": [ { "name": "Test Product (A): Fluorouracil Cream, 5% topical cream", "type": "DRUG" }, { "name": "Reference Product (B): Fluorouracil 5% Topical Cream of Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.", "type": "DRUG" }, { "name": "Placebo Product (C): Test vehicle cream for fluorouracil 5% of Encube Ethicals Pvt. Ltd., India", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Encube Ethicals Pvt. Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 458, "start_date": "2022-03-01", "completion_date": "2022-12-01", "has_results": false, "last_update_posted_date": "2023-03-14", "last_synced_at": "2026-09-23T11:45:00.668Z", "location_count": 7, "location_summary": "Bakersfield, California • Cerritos, California • Lauderdale Lakes, Florida + 3 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Lauderdale Lakes", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05078827" } ] }